Anil Malik
About Anil Malik
Data last updated:
Anil Malik is a Director at Zenith Drugs Limited (since 2023). The company operates in Pharma. Zenith Drugs Limited reported revenue of ₹136 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zenith Drugs Limited L24231MP2000PLC014465 | Director | 25 Sep 2023 | 2000 | ₹136 Cr (FY 2025) | Active |
Board colleagues of Anil Malik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Singh Dassundi | 00835856 | Zenith Drugs Limited | Director |
| Bhupesh Soni | 00539355 | Zenith Drugs Limited | Director |
| Deendayal Kumawat | 10332223 | Zenith Drugs Limited | Director |
| Rajesh Agrawal | Zenith Drugs Limited | Cfo | |
| Ranjana Sureshkumar Sehgal | 01979256 | Zenith Drugs Limited | Director |
| Sakshi Bhawsar | Zenith Drugs Limited | Company Secretary | |
| Sandeep Bhardwaj | 00539347 | Zenith Drugs Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anil Malik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anil Malik
Anil Malik currently holds 1 directorship: Zenith Drugs Limited (Director, since 25 Sep 2023, revenue ₹136 Cr (FY 2025)).
Anil Malik was first appointed on 25 Sep 2023 as Director at Zenith Drugs Limited.
The current boards of Anil Malik's companies include Ajay Singh Dassundi (Zenith Drugs Limited), Bhupesh Soni (Zenith Drugs Limited), Deendayal Kumawat (Zenith Drugs Limited), Rajesh Agrawal (Zenith Drugs Limited), Ranjana Sureshkumar Sehgal (Zenith Drugs Limited), Sakshi Bhawsar (Zenith Drugs Limited), among others.